{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T20:24:06Z","timestamp":1743539046618,"version":"3.37.3"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,7,23]],"date-time":"2022-07-23T00:00:00Z","timestamp":1658534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,23]],"date-time":"2022-07-23T00:00:00Z","timestamp":1658534400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Ministry of Health and Welfare of the Republic of Korea","award":["HI20C0410"],"award-info":[{"award-number":["HI20C0410"]}]},{"name":"GNTPharma"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Ischemic brain injury is a major hurdle that limits the survival of resuscitated out-of-hospital cardiac arrest (OHCA).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The aim of this study is to assess the feasibility and potential for reduction of ischemic brain injury in adult OHCA patients treated with high- or low-dose Neu2000K, a selective blocker of <jats:italic>N<\/jats:italic>-methyl-<jats:sc>d<\/jats:sc>-aspartate (NMDA) type 2B receptor and also a free radical scavenger, or given placebo. This study is a phase II, multicenter, randomized, double-blinded, prospective, intention-to-treat, placebo-controlled, three-armed, safety and efficacy clinical trial. This trial is a sponsor-initiated trial supported by GNT Pharma. Successfully resuscitated OHCA patients aged 19 to 80\u00a0years would be included. The primary outcome is blood neuron-specific enolase (NSE) level on the 3rd day. The secondary outcomes are safety, efficacy defined by study drug administration within 4\u00a0h in\u2009&gt;\u200990% of participants, daily NSE up to 5th day, blood S100beta, brain MRI apparent diffusion coefficient imaging, cerebral performance category (CPC), and Modified Rankin Scale (mRS) at 5th, 14th, and 90th days. Assuming NSE of 42\u2009\u00b1\u200980 and 80\u2009\u00b1\u200980\u00a0\u03bcg\/L in the treatment (high- and low-dose Neu2000K) and control arms with 80% power, a type 1 error rate of 5%, and a 28% of withdrawal prior to the endpoint, the required sample size is 150 patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Discussion<\/jats:title>\n                <jats:p>The AWAKE trial explores a new multi-target neuroprotectant for the treatment of resuscitated OHCA patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>ClinicalTrials.gov <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03651557\">NCT03651557<\/jats:ext-link>. Registered on August 29, 2018.\n<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13063-022-06452-0","type":"journal-article","created":{"date-parts":[[2022,7,23]],"date-time":"2022-07-23T11:02:43Z","timestamp":1658574163000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Rationale and methods of the Antioxidant and NMDA receptor blocker Weans Anoxic brain damage of KorEa OHCA patients (AWAKE) trial"],"prefix":"10.1186","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4839-913X","authenticated-orcid":false,"given":"Jin-Ho","family":"Choi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Byeong Jo","family":"Chun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seok Ran","family":"Yeom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung Phil","family":"Chung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young Hwan","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun-Hee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji Sung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin Hwan","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hwan Goo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing Yu","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun San","family":"An","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Byoung Joo","family":"Gwag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,7,23]]},"reference":[{"key":"6452_CR1","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1016\/j.resuscitation.2010.08.006","volume":"81","author":"J Berdowski","year":"2010","unstructured":"Berdowski J, Berg RA, Tijssen JGP, et al. Global incidences of out-of-hospital cardiac arrest and survival rates: systematic review of 67 prospective studies. Resuscitation. 2010;81:1479\u201387.","journal-title":"Resuscitation"},{"key":"6452_CR2","doi-asserted-by":"publisher","first-page":"e254","DOI":"10.1161\/CIR.0000000000000950","volume":"143","author":"SS Virani","year":"2021","unstructured":"Virani SS, Alonso A, Aparicio HJ, et al. Heart disease and stroke statistics\u20142021 update. Circulation. 2021;143:e254\u2013743.","journal-title":"Circulation"},{"key":"6452_CR3","doi-asserted-by":"publisher","first-page":"165","DOI":"10.15441\/ceem.17.259","volume":"5","author":"JY Kim","year":"2018","unstructured":"Kim JY, Hwang SOSS, Shin S Do, et al. Korean Cardiac Arrest Research Consortium (KoCARC): rationale, development, and implementation. Clin Exp Emerg Med. 2018;5:165\u201376.","journal-title":"Clin Exp Emerg Med."},{"key":"6452_CR4","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.resuscitation.2019.12.042","volume":"148","author":"J-T Gr\u00e4sner","year":"2020","unstructured":"Gr\u00e4sner J-T, Wnent J, Herlitz J, et al. Survival after out-of-hospital cardiac arrest in Europe - results of the EuReCa TWO study. Resuscitation. 2020;148:218\u201326.","journal-title":"Resuscitation"},{"key":"6452_CR5","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.120.016521","volume":"9","author":"M Dennis","year":"2020","unstructured":"Dennis M, Lal S, Forrest P, et al. In-depth extracorporeal cardiopulmonary resuscitation in adult out-of-hospital cardiac arrest. J Am Heart Assoc. 2020;9: e016521.","journal-title":"J Am Heart Assoc"},{"key":"6452_CR6","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1097\/CCM.0000000000000406","volume":"42","author":"JH Kilgannon","year":"2014","unstructured":"Kilgannon JH, Roberts BW, Jones AE, et al. Arterial blood pressure and neurologic outcome after resuscitation from cardiac arrest*. Crit Care Med. 2014;42:2083\u201391.","journal-title":"Crit Care Med"},{"key":"6452_CR7","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.3389\/fnins.2020.579953","volume":"14","author":"DW Choi","year":"2020","unstructured":"Choi DW. Excitotoxicity: still hammering the ischemic brain in 2020. Front Neurosci. 2020;14:1104.","journal-title":"Front Neurosci"},{"key":"6452_CR8","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/jnc.14970","volume":"154","author":"M Vieira","year":"2020","unstructured":"Vieira M, Yong XLH, Roche KW, et al. Regulation of NMDA glutamate receptor functions by the GluN2 subunits. J Neurochem. 2020;154:121\u201343.","journal-title":"J Neurochem"},{"key":"6452_CR9","doi-asserted-by":"publisher","first-page":"9854","DOI":"10.1073\/pnas.0903546106","volume":"106","author":"RI Stanika","year":"2009","unstructured":"Stanika RI, Pivovarova NB, Brantner CA, et al. Coupling diverse routes of calcium entry to mitochondrial dysfunction and glutamate excitotoxicity. Proc Natl Acad Sci. 2009;106:9854\u20139.","journal-title":"Proc Natl Acad Sci"},{"key":"6452_CR10","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1038\/s41467-017-02322-5","volume":"8","author":"J Pose-Utrilla","year":"2017","unstructured":"Pose-Utrilla J, Garc\u00eda-Guerra L, Del Puerto A, et al. Excitotoxic inactivation of constitutive oxidative stress detoxification pathway in neurons can be rescued by PKD1. Nat Commun. 2017;8:2275.","journal-title":"Nat Commun"},{"key":"6452_CR11","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1358\/dnp.2010.23.9.1513493","volume":"23","author":"SJ Cho","year":"2010","unstructured":"Cho SJ, Park UJ, Chung J-M, et al. Neu 2000, an NR2B-selective, moderate NMDA receptor antagonist and potent spin trapping molecule for stroke. Drug News Perspect. 2010;23:549.","journal-title":"Drug News Perspect"},{"key":"6452_CR12","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13041-018-0357-8","volume":"11","author":"QJ Wu","year":"2018","unstructured":"Wu QJ, Tymianski M. Targeting NMDA receptors in stroke: new hope in neuroprotection. Mol Brain. 2018;11:15.","journal-title":"Mol Brain"},{"key":"6452_CR13","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.pneurobio.2013.11.006","volume":"115","author":"TW Lai","year":"2014","unstructured":"Lai TW, Zhang S, Wang YT. Excitotoxicity and stroke: identifying novel targets for neuroprotection. Prog Neurobiol. 2014;115:157\u201388.","journal-title":"Prog Neurobiol"},{"key":"6452_CR14","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.neuropharm.2007.12.007","volume":"55","author":"MD Ginsberg","year":"2008","unstructured":"Ginsberg MD. Neuroprotection for ischemic stroke: past, present and future. Neuropharmacology. 2008;55:363\u201389.","journal-title":"Neuropharmacology"},{"key":"6452_CR15","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1046\/j.1471-4159.2003.01724.x","volume":"85","author":"WJ Yoon","year":"2003","unstructured":"Yoon WJ, Won SJ, Ryu BR, et al. Blockade of ionotropic glutamate receptors produces neuronal apoptosis through the Bax-cytochrome C-caspase pathway: the causative role of Ca2+ deficiency. J Neurochem. 2003;85:525\u201333.","journal-title":"J Neurochem"},{"key":"6452_CR16","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/0306-4522(95)00232-8","volume":"68","author":"BJ Gwag","year":"1995","unstructured":"Gwag BJ, Lobner D, Koh JY, et al. Blockade of glutamate receptors unmasks neuronal apoptosis after oxygen-glucose deprivation in vitro. Neuroscience. 1995;68:615\u20139.","journal-title":"Neuroscience"},{"key":"6452_CR17","doi-asserted-by":"publisher","first-page":"8849","DOI":"10.1523\/JNEUROSCI.19-20-08849.1999","volume":"19","author":"SY Seo","year":"1999","unstructured":"Seo SY, Kim EY, Kim H, et al. Neuroprotective effect of high glucose against NMDA, free radical, and oxygen\u2013glucose deprivation through enhanced mitochondrial potentials. J Neurosci. 1999;19:8849.","journal-title":"J Neurosci"},{"key":"6452_CR18","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1124\/mol.106.030676","volume":"71","author":"JH Shin","year":"2007","unstructured":"Shin JH, Cho SI, Lim HR, et al. Concurrent administration of Neu 2000 and lithium produces marked improvement of motor neuron survival, motor function, and mortality in a mouse model of amyotrophic lateral sclerosis. Mol Pharmacol. 2007;71:965\u201375.","journal-title":"Mol Pharmacol"},{"key":"6452_CR19","doi-asserted-by":"publisher","first-page":"A7","DOI":"10.1038\/399a007","volume":"399","author":"J-M Lee","year":"1999","unstructured":"Lee J-M, Zipfel GJ, Choi DW. The changing landscape of ischaemic brain injury mechanisms. Nature. 1999;399:A7\u201314.","journal-title":"Nature"},{"key":"6452_CR20","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1161\/01.STR.30.10.2038","volume":"30","author":"AG Dyker","year":"1999","unstructured":"Dyker AG, Edwards KR, Fayad PB, et al. Safety and tolerability study of aptiganel hydrochloride in patients with an acute ischemic stroke. Stroke. 1999;30:2038\u201342.","journal-title":"Stroke"},{"key":"6452_CR21","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1007\/s004150200065","volume":"249","author":"H-C Diener","year":"2002","unstructured":"Diener H-C, AlKhedr A, Busse O, et al. Treatment of acute ischaemic stroke with the low-affinity, use-dependent NMDA antagonist AR-R15896AR. J Neurol. 2002;249:561\u20138.","journal-title":"J Neurol"},{"key":"6452_CR22","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1038\/sj.jcbfm.9600418","volume":"27","author":"BJ Gwag","year":"2007","unstructured":"Gwag BJ, Lee YA, Ko SY, et al. Marked prevention of ischemic brain injury by Neu 2000, an NMDA antagonist and antioxidant derived from aspirin and sulfasalazine. J Cereb Blood Flow Metab. 2007;27:1142\u201351.","journal-title":"J Cereb Blood Flow Metab"},{"key":"6452_CR23","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1097\/00001756-200211150-00001","volume":"13","author":"G Kvrivishvili","year":"2002","unstructured":"Kvrivishvili G. Glycine and neuroprotective effect of hypothermia in hypoxic\u2013ischemic brain damage. NeuroReport. 2002;13:1995\u20132000.","journal-title":"NeuroReport"},{"key":"6452_CR24","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S0006-8993(00)02861-4","volume":"884","author":"H Ooboshi","year":"2000","unstructured":"Ooboshi H, Ibayashi S, Takano K, et al. Hypothermia inhibits ischemia-induced efflux of amino acids and neuronal damage in the hippocampus of aged rats. Brain Res. 2000;884:23\u201330.","journal-title":"Brain Res"},{"key":"6452_CR25","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3389\/fneur.2011.00004","volume":"2","author":"FP Gonz\u00e1lez-Ibarra","year":"2011","unstructured":"Gonz\u00e1lez-Ibarra FP, Varon J, L\u00f3pez-Meza EG. Therapeutic hypothermia: critical review of the molecular mechanisms of action. Front Neurol. 2011;2:4.","journal-title":"Front Neurol"},{"key":"6452_CR26","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1042\/BST0371147","volume":"37","author":"GE Hardingham","year":"2009","unstructured":"Hardingham GE. Coupling of the NMDA receptor to neuroprotective and neurodestructive events. Biochem Soc Trans. 2009;37:1147\u201360.","journal-title":"Biochem Soc Trans"},{"key":"6452_CR27","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1038\/nn2071","volume":"11","author":"S Papadia","year":"2008","unstructured":"Papadia S, Soriano FX, L\u00e9veill\u00e9 F, et al. Synaptic NMDA receptor activity boosts intrinsic antioxidant defenses. Nat Neurosci. 2008;11:476\u201387.","journal-title":"Nat Neurosci"},{"key":"6452_CR28","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/j.tiv.2012.12.011","volume":"27","author":"NP Visavadiya","year":"2013","unstructured":"Visavadiya NP, McEwen ML, Pandya JD, et al. Antioxidant properties of Neu 2000 on mitochondrial free radicals and oxidative damage. Toxicol Vitr. 2013;27:788\u201397.","journal-title":"Toxicol Vitr."},{"key":"6452_CR29","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s00401-010-0785-8","volume":"121","author":"UJ Park","year":"2011","unstructured":"Park UJ, Lee YA, Won SM, et al. Blood-derived iron mediates free radical production and neuronal death in the hippocampal CA1 area following transient forebrain ischemia in rat. Acta Neuropathol. 2011;121:459\u201373.","journal-title":"Acta Neuropathol."},{"key":"6452_CR30","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3858\/emm.2011.43.2.020","volume":"43","author":"SM Won","year":"2011","unstructured":"Won SM, Lee JH, Park UJ, et al. Iron mediates endothelial cell damage and blood-brain barrier opening in the hippocampus after transient forebrain ischemia in rats. Exp Mol Med. 2011;43:121.","journal-title":"Exp Mol Med."},{"key":"6452_CR31","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.resuscitation.2016.03.023","volume":"104","author":"GM Eastwood","year":"2016","unstructured":"Eastwood GM, Schneider AG, Suzuki S, et al. Targeted therapeutic mild hypercapnia after cardiac arrest: A phase II multi-centre randomised controlled trial (the CCC trial). Resuscitation. 2016;104:83\u201390.","journal-title":"Resuscitation."},{"key":"6452_CR32","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1161\/CIRCULATIONAHA.120.053318","volume":"143","author":"MAS Meyer","year":"2021","unstructured":"Meyer MAS, Wiberg S, Grand J, et al. Treatment effects of interleukin-6 receptor antibodies for modulating the systemic inflammatory response after out-of-hospital cardiac arrest (The IMICA trial): A double-blinded, placebo-controlled, single-center, randomized,\u00a0clinical trial. Circulation. 2021;143:1841\u201351.","journal-title":"Circulation"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-022-06452-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-022-06452-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-022-06452-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,23]],"date-time":"2022-07-23T11:10:07Z","timestamp":1658574607000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-022-06452-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,23]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["6452"],"URL":"https:\/\/doi.org\/10.1186\/s13063-022-06452-0","relation":{},"ISSN":["1745-6215"],"issn-type":[{"type":"electronic","value":"1745-6215"}],"subject":[],"published":{"date-parts":[[2022,7,23]]},"assertion":[{"value":"7 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This trial will be conducted in accordance with the Declaration of Helsinki and international standards of Good Clinical Practice (GCP). The trial protocol has been approved by the Ministry of Food and Drug Safety of Korea on December 20, 2017 (# 11771), and was approved by the Institutional Review Board of Samsung Medical Center and each participating institute.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate\u00a0{24}"}},{"value":"The model consent forms given to the participants and authorized surrogates are written in the Korean language and available on reasonable request.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication\u00a0{32}"}},{"value":"J.L., G.L., J.J., C.A., and B.G. are employees of GNT Pharma. All the other authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests\u00a0{28}"}}],"article-number":"587"}}